Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests

QR Code

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests

Bibliographic Details
Main Authors:	Bates, K., Verdile, Giuseppe, Li, Q., Ames, D., Hudson, P., Masters, C., Martins, R.
Format:	Journal Article
Published:	Nature Publishing Group 2009
Online Access:	http://hdl.handle.net/20.500.11937/15995

Similar Items

Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

A yeast model for studying intracellular clearance of beta-amyloid 42
by: Bharadwaj, Prashant, et al.
Published: (2012)

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor
by: Xie, Ling, et al.
Published: (2002)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism
by: Verdile, Giuseppe, et al.
Published: (2009)

Amyloid-ß and islet amyloid pathologies link Alzheimer disease and type 2 diabetes in a transgenic model.
by: Wijesekara, N., et al.
Published: (2017)

Molecular docking studies on the interaction of anti-alzheimer compounds with amyloid beta peptides
by: Faujan, Nur Hana, et al.
Published: (2019)

Immunization in Alzheimer’s disease: Naïve hope or realistic clinical potential?
by: Foster, Jonathan, et al.
Published: (2009)

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)

Enterocyte Beta Amyloid-Lipoprotein Homeostasis: Implications for Alzheimer's Disease Risk
by: Galloway, Susan
Published: (2015)

Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity
by: Taddei, K., et al.
Published: (2010)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

Plasma lipoprotein b-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
by: Mamo, John, et al.
Published: (2008)

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
by: Bharadwaj, P., et al.
Published: (2013)

The Effects of Latrepirdine on Amyloid-ß Aggregation and Toxicity
by: Porter, T., et al.
Published: (2016)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Validation and characterisation of a novel peptide that binds monomeric and aggregated beta-amyloid and inhibits the formation of neurotoxic oligomers
by: Barr, R., et al.
Published: (2015)

Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)

Ovariectomy and 17ß-estradiol replacement do not alter ß-amyloid levels in sheep brain
by: Barron, A., et al.
Published: (2009)

Reproductive Hormones Modulate Oxidative Stress in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2006)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

Molecular simulation between amyloid beta (1-42), a Peptide associated with alzheimer disease, and zinc(ii) ion
by: Abdul Ghani, Nur Syafiqah
Published: (2016)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

Autoantibody-catalyzed hydrolysis of amyloid ß peptide
by: Taguchi, H., et al.
Published: (2008)

Role of the cell membrane interface in modulating production and uptake of Alzheimer's beta amyloid protein
by: Bharadwaj, Prashant, et al.
Published: (2018)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

Interactive Effects of Dietary Fat and APOE Genotype on Peripheral Amyloid-Beta: Implications for Alzheimer’s Disease Risk
by: D'Alonzo, Zachary John
Published: (2025)

Alzheimer's amyloid-ß rescues yeast from hydroxide toxicity
by: Dubey, A., et al.
Published: (2009)

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels
by: Wahjoepramono, E., et al.
Published: (2011)

Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue
by: Sharif, Arazu
Published: (2024)

Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)

Carbohydrate-mimetic peptides: structural aspects of mimicry and therapeutic implications
by: Agostino, Mark, et al.
Published: (2011)

Modulation of Amyloid Beta (Aß) Structure and Toxicity by a Dairy-derived Peptide Product
by: Bennett, L., et al.
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sqq896u1i6uchnisgv547nnjnc